Skip to main content
Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · IEX Real-Time Price · USD
1.660
-0.010 (-0.60%)
At close: Jul 19, 2024, 4:00 PM
1.685
+0.025 (1.51%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Ikena Oncology Revenue

Ikena Oncology had revenue of $3.85M in the twelve months ending March 31, 2024. In the year 2023, Ikena Oncology had annual revenue of $9.16M.

Revenue (ttm)
$3.85M
Revenue Growth
-78.07%
P/S Ratio
20.82
Revenue / Employee
$89,488
Employees
43
Market Cap
80.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.16M-6.46M-41.35%
Dec 31, 202215.62M-15.37M-49.59%
Dec 31, 202130.99M21.79M237.01%
Dec 31, 20209.19M-4.56M-33.15%
Dec 31, 201913.75M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SCYNEXIS 140.39M
Protalix BioTherapeutics 59.65M
DBV Technologies 14.94M
Nutriband 2.02M
Chimerix 41.00K
Revenue Rankings

IKNA News

More News